NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 142 filers reported holding NEVRO CORP in Q1 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,514,536 | -23.4% | 78,800 | +1.3% | 0.00% | 0.0% |
| Q2 2023 | $1,977,676 | -24.6% | 77,800 | +7.2% | 0.00% | -50.0% |
| Q1 2023 | $2,624,490 | -18.3% | 72,600 | -10.5% | 0.00% | 0.0% |
| Q4 2022 | $3,211,560 | -13.2% | 81,100 | +2.1% | 0.00% | -33.3% |
| Q3 2022 | $3,700,000 | +7.5% | 79,400 | +1.1% | 0.00% | +50.0% |
| Q2 2022 | $3,441,000 | -39.4% | 78,500 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $5,678,000 | -4.1% | 78,500 | +7.5% | 0.00% | -25.0% |
| Q4 2021 | $5,918,000 | -30.3% | 73,000 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $8,496,000 | -29.3% | 73,000 | +0.7% | 0.01% | -28.6% |
| Q2 2021 | $12,020,000 | +15.2% | 72,500 | -3.1% | 0.01% | 0.0% |
| Q1 2021 | $10,435,000 | -18.2% | 74,800 | +1.5% | 0.01% | -22.2% |
| Q4 2020 | $12,757,000 | +25.1% | 73,700 | +0.7% | 0.01% | +12.5% |
| Q3 2020 | $10,197,000 | +26.5% | 73,200 | +8.4% | 0.01% | +14.3% |
| Q2 2020 | $8,064,000 | +34.2% | 67,500 | +12.3% | 0.01% | +16.7% |
| Q1 2020 | $6,009,000 | -13.5% | 60,100 | +1.7% | 0.01% | -14.3% |
| Q4 2019 | $6,947,000 | +40.8% | 59,100 | +3.0% | 0.01% | +40.0% |
| Q3 2019 | $4,935,000 | +34.7% | 57,400 | +1.6% | 0.01% | +25.0% |
| Q2 2019 | $3,663,000 | +18.4% | 56,500 | +14.1% | 0.00% | +33.3% |
| Q1 2019 | $3,094,000 | +66.1% | 49,500 | +3.3% | 0.00% | +50.0% |
| Q4 2018 | $1,863,000 | -30.0% | 47,900 | +2.6% | 0.00% | -33.3% |
| Q3 2018 | $2,662,000 | -28.6% | 46,700 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $3,729,000 | +4.7% | 46,700 | +13.6% | 0.00% | 0.0% |
| Q1 2018 | $3,562,000 | +28.6% | 41,100 | +2.5% | 0.00% | +33.3% |
| Q4 2017 | $2,769,000 | -21.7% | 40,100 | +3.1% | 0.00% | -25.0% |
| Q3 2017 | $3,535,000 | +22.1% | 38,900 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $2,895,000 | -13.5% | 38,900 | +9.0% | 0.00% | -25.0% |
| Q1 2017 | $3,345,000 | +30.8% | 35,700 | +1.4% | 0.00% | 0.0% |
| Q4 2016 | $2,558,000 | -28.8% | 35,200 | +2.3% | 0.00% | -33.3% |
| Q3 2016 | $3,591,000 | +44.4% | 34,400 | +2.1% | 0.01% | +50.0% |
| Q2 2016 | $2,486,000 | +79.4% | 33,700 | +32.2% | 0.00% | +33.3% |
| Q1 2016 | $1,386,000 | +6.9% | 25,500 | +32.8% | 0.00% | 0.0% |
| Q4 2015 | $1,296,000 | +51.8% | 19,200 | +4.3% | 0.00% | +50.0% |
| Q3 2015 | $854,000 | -0.1% | 18,400 | +15.7% | 0.00% | 0.0% |
| Q2 2015 | $855,000 | – | 15,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |